ANTERIX INC (ATEX) Fundamental Analysis & Valuation

NASDAQ:ATEX • US03676C1009

Current stock price

47.21 USD
+2.04 (+4.52%)
At close:
47.21 USD
0 (0%)
After Hours:

This ATEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ATEX Profitability Analysis

1.1 Basic Checks

  • ATEX had positive earnings in the past year.
  • ATEX had a negative operating cash flow in the past year.
  • In the past 5 years ATEX always reported negative net income.
  • In multiple years ATEX reported negative operating cash flow during the last 5 years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

  • ATEX has a better Return On Assets (19.50%) than 100.00% of its industry peers.
  • ATEX's Return On Equity of 34.47% is amongst the best of the industry. ATEX outperforms 97.30% of its industry peers.
Industry RankSector Rank
ROA 19.5%
ROE 34.47%
ROIC N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

  • ATEX's Profit Margin of 1370.92% is amongst the best of the industry. ATEX outperforms 100.00% of its industry peers.
  • ATEX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 1370.92%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ATEX Health Analysis

2.1 Basic Checks

  • ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ATEX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ATEX has more shares outstanding
  • There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • ATEX has an Altman-Z score of 1.45. This is a bad value and indicates that ATEX is not financially healthy and even has some risk of bankruptcy.
  • ATEX has a better Altman-Z score (1.45) than 70.27% of its industry peers.
  • There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACCN/A
WACC8.95%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • ATEX has a Current Ratio of 1.39. This is a normal value and indicates that ATEX is financially healthy and should not expect problems in meeting its short term obligations.
  • ATEX has a Current ratio (1.39) which is comparable to the rest of the industry.
  • ATEX has a Quick Ratio of 1.39. This is a normal value and indicates that ATEX is financially healthy and should not expect problems in meeting its short term obligations.
  • ATEX has a better Quick ratio (1.39) than 64.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ATEX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 366.87% over the past year.
  • The Revenue has been growing slightly by 0.51% in the past year.
  • ATEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.05% yearly.
EPS 1Y (TTM)366.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.37%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%0.45%

3.2 Future

  • ATEX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -46.56% yearly.
  • ATEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.34% yearly.
EPS Next Y841.52%
EPS Next 2Y-46.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.07%
Revenue Next 2Y4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. ATEX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.85, the valuation of ATEX can be described as reasonable.
  • Based on the Price/Earnings ratio, ATEX is valued cheaply inside the industry as 86.49% of the companies are valued more expensively.
  • ATEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.35.
  • The Forward Price/Earnings Ratio is negative for ATEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 10.85
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as ATEX's earnings are expected to decrease with -46.56% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y-46.56%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ATEX Dividend Analysis

5.1 Amount

  • No dividends for ATEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ATEX Fundamentals: All Metrics, Ratios and Statistics

ANTERIX INC

NASDAQ:ATEX (4/27/2026, 8:00:01 PM)

After market: 47.21 0 (0%)

47.21

+2.04 (+4.52%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-11
Earnings (Next)06-22
Inst Owners88.29%
Inst Owner Change-0.12%
Ins Owners1.86%
Ins Owner Change-0.27%
Market Cap884.24M
Revenue(TTM)5.93M
Net Income(TTM)81.32M
Analysts82.22
Price Target56.44 (19.55%)
Short Float %8.67%
Short Ratio4.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)302.47%
Min EPS beat(2)37.61%
Max EPS beat(2)567.32%
EPS beat(4)4
Avg EPS beat(4)285.39%
Min EPS beat(4)37.61%
Max EPS beat(4)567.32%
EPS beat(8)5
Avg EPS beat(8)149.32%
EPS beat(12)9
Avg EPS beat(12)137.41%
EPS beat(16)11
Avg EPS beat(16)84.01%
Revenue beat(2)2
Avg Revenue beat(2)4%
Min Revenue beat(2)3.35%
Max Revenue beat(2)4.65%
Revenue beat(4)2
Avg Revenue beat(4)-5.05%
Min Revenue beat(4)-20.4%
Max Revenue beat(4)4.65%
Revenue beat(8)2
Avg Revenue beat(8)-10.62%
Revenue beat(12)3
Avg Revenue beat(12)-13.91%
Revenue beat(16)4
Avg Revenue beat(16)-11.7%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.18%
EPS NY rev (1m)0%
EPS NY rev (3m)5.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.31%
Valuation
Industry RankSector Rank
PE 10.85
Fwd PE N/A
P/S 149.06
P/FCF N/A
P/OCF N/A
P/B 3.75
P/tB N/A
EV/EBITDA N/A
EPS(TTM)4.35
EY9.21%
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-2.77
FCFYN/A
OCF(TTM)-1.42
OCFYN/A
SpS0.32
BVpS12.6
TBVpS-5.06
PEG (NY)0.01
PEG (5Y)N/A
Graham Number35.1138 (-25.62%)
Profitability
Industry RankSector Rank
ROA 19.5%
ROE 34.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1370.92%
GM N/A
FCFM N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5796.11%
Cap/Sales 426.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z 1.45
F-Score5
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)2427.57%
Cap/Depr(5y)1914.89%
Cap/Sales(3y)709.4%
Cap/Sales(5y)1241.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)366.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.37%
EPS Next Y841.52%
EPS Next 2Y-46.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.51%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%0.45%
Revenue Next Year-1.07%
Revenue Next 2Y4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1012.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-197.36%
OCF growth 3YN/A
OCF growth 5YN/A

ANTERIX INC / ATEX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ANTERIX INC?

ChartMill assigns a fundamental rating of 4 / 10 to ATEX.


What is the valuation status of ANTERIX INC (ATEX) stock?

ChartMill assigns a valuation rating of 3 / 10 to ANTERIX INC (ATEX). This can be considered as Overvalued.


How profitable is ANTERIX INC (ATEX) stock?

ANTERIX INC (ATEX) has a profitability rating of 3 / 10.


How financially healthy is ANTERIX INC?

The financial health rating of ANTERIX INC (ATEX) is 6 / 10.